Fighting antimicrobial resistance: SNIPR Biome Secures €35 Million Series B

Antibiotic resistance has become a real problem in the 21st century, as more and more people take these medications to treat diseases. Inappropriate medication use has also contributed to the rise in antibiotic resistance. Consequently, that’s why there’s a problem that needs to be solved to fight diseases. Copenhagen-based BioTech scale-up SNIPR Biome has recently raised €35 million to fight antibiotic resistance.

In this regard, the startup is about to advance CRISPR-based therapies targeting antibiotic-resistant infections and blood cancers. The company develops precision CRISPR-medicine that selectively kills harmful bacteria, removes antibiotic resistance genes, and produces therapeutics in targeted regions of the gut.

Among new investors are the Cystic Fibrosis Foundation and Germany’s SPRIN-D. They joined the existing backers Lundbeckfonden BioCapital, North-East Family Office, and Wellington Partners. CEO Christian Grøndahl said, “This financing is a milestone as we advance SNIPR001 and expand our infectious disease pipeline targeting critical pathogens.”

Advancing CRISPR Therapies and Clinical Trials

SNIPR001 is in a Phase 1b trial at eight U.S. cancer centers for blood cancer patients. The funding will also support therapies for cystic fibrosis airway infections and microbial interventions. These therapies are about to eliminate antibiotic resistance genes across bacterial species.

SNIPR Biome has reportedly been the first company to orally dose humans with CRISPR therapeutics and to secure U.S. and European patents for microbiome-targeting CRISPR medicine. Moreover, the platform collaborates with CARB-X, the Gates Foundation, IPATH, MD Anderson Cancer Center, and the Cystic Fibrosis Foundation.

At IGF, we support startups like SNIPR Biome that translate innovative science into impactful therapies. This marks the beginning of an important path in fighting antibiotic resistance. Moreover, at IGF, we support investors and startups that create bright ideas that change healthcare. Contact us now to bring your idea to life.